Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 4036-4044

  Moreno Navarrete, J M ^b   Ortega, F J ^b   Bassols, J ^b   Ricart, W ^b   Fernandez Real J M ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFERRIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; ROSIGLITAZONE;

ADULT; ARTICLE; BLOOD CULTURE; CAUCASIAN; CONTROLLED STUDY; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 70349923422     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0215     Document Type: Article

References (42)

1. Fernandez-Real JM, Ricart W 2003 Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301 (Pubitemid 36724371)
2. Hotamisligil GS 2003 Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27(Suppl 3):S53-S55
3. Dandona P, Aljada A, Bandyopadhyay A 2004 Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7 (Pubitemid 38032801)
4. He J, Usui I, Ishizuka K, Kanatani Y, Hiratani K, Iwata M, Bukhari A, Haruta T, Sasaoka T, Kobayashi M 2006 Interleukin-1α inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes. Mol Endocrinol 20:114-124 (Pubitemid 43011674)
5. Rotter V, Nagaev I, Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor-necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784 (Pubitemid 37432722)
6. Senn JJ, Klover PJ, Nowak IA, Mooney RA 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399 (Pubitemid 35403441)
7. Stephens JM, Lee J, Pilch PF 1997 Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272: 971-976 (Pubitemid 27034588)
8. Lee JY, Hwang DH 2006 The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 21:174-185
9. Song MJ, Kim KH, Yoon JM, Kim JB 2006 Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739-745
10. Tan KC, Chow WS, Tam S, Bucala R, Betteridge J 2004 Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 27:223-228 (Pubitemid 38196736)
11. Fernandez-Real JM, Lopez-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W 2006 Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 29:1058-1064 (Pubitemid 44115244)
12. Ceriello A, Motz E 2004 Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-823 (Pubitemid 38620857)
13. Baker EN, Baker HM 2005 Molecular structure, binding properties and dynamics of lactoferrin. Cell Mol Life Sci 62:2531-2539 (Pubitemid 41721228)
14. Otsuki K, Yakuwa K, Sawada M, Hasegawa A, Sasaki Y, Mitsukawa K, Chiba H, Nagatsuka M, Saito H, Okai T 2005 Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J Perinat Med 33:320-323 (Pubitemid 41205865)
15. Conneely OM 2001 Antiinflammatory activities of lactoferrin. J Am Coll Nutr 20:389S-395S; discussion 396S-397S
16. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I 2002 Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell Immunol 220:83-95 (Pubitemid 36349060)
17. Kruzel ML, Harari Y, Chen CY, Castro GA 1998 The gut. A key metabolic organ protected by lactoferrin during experimental systemic inflammation in mice. Adv Exp Med Biol 443:167-173
18. Moreno-Navarrete JM, Ortega FJ, Bassols J, Castro A, Ricart W, Fernandez-Real JM 2008 Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia inmendepends on glucose-tolerance status. ClinChem 54:301-309 (Pubitemid 351302631)
19. Bergman RN, Prager R, Volund A, Olefsky JM 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 79:790-800 (Pubitemid 17050904)
20. Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC 2004 Tumor necrosis factor-α in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 23:319-329 (Pubitemid 39552305)
21. Langezaal I, Coecke S, Hartung T 2001 Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro 15:313-318 (Pubitemid 32889650)
22. Doyle SL, Jefferies CA, O'Neill LA 2005 Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFκB activation by lipopolysaccharide. J Biol Chem 280:23496-23501
23. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772 (Pubitemid 47025442)
24. Japelj B, Pristovsek P, Majerle A, Jerala R 2005 Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J Biol Chem 280:16955-16961 (Pubitemid 41389156)
25. Ward PP, Uribe-Luna S, Conneely OM 2002 Lactoferrin and host defense. Biochem Cell Biol 80:95-102
26. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D 2000 Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 68:6519-6525 (Pubitemid 32463349)
27. Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, Kristal B 2001 Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 24:104-110 (Pubitemid 32104229)
28. Advani A, Marshall SM, Thomas TH 2002 Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in type II diabetes. Diabetologia 45:719-727 (Pubitemid 34810697)
29. Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS 2006 The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract 73:284-291
30. Stegenga ME,van der Crabben SN, Blümer RM, Levi M, Meijers JC, Serlie MJ, Tanck MW, Sauerwein HP, van der Poll T 2008 Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 112:82-89
31. Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM 2006 Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55:216-224 (Pubitemid 43343318)
32. Koivuranta-Vaara P, Banda D, Goldstein IM 1987 Bacterial- lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor α. Infect Immun 55:2956-2961 (Pubitemid 18008264)
33. Srivastava CH, Rado TA, Bauerle D, Broxmeyer HE 1991 Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-α. J Immunol 146:1014-1019
34. Zimecki M, Chodaczek G, Kocieba M, Kruzel ML 2004 Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin. FEMS Immunol Med Microbiol 42:167-172 (Pubitemid 39208543)
35. Fernández-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C 1998 Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47:1757-1762 (Pubitemid 28476250)
36. Legrand D, Elass E, Carpentier M, Mazurier J 2005 Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci 62:2549-2559 (Pubitemid 41722207)
37. Walrand S, Guillet C, Boirie Y, Vasson MP 2006 Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. J Clin Endocrinol Metab 91:2738-2748 (Pubitemid 44024646)
38. Walrand S, Guillet C, Boirie Y, Vasson MP 2004 In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions. J Leukoc Biol 76:1104-1110
39. Buitenhuis M, Verhagen LP, van Deutekom HW, Castor A, Verploegen S, Koenderman L, Jacobsen SE, Coffer PJ 2008 Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis. Blood 111:112-121
40. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P 2004 Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab 89:2728-2735 (Pubitemid 38766357)
41. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S 2001 Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 86:3257-3265
42. Jeschke MG, Klein D, Thasler WE, Bolder U, Schlitt HJ, Jauch KW, Weiss TS 2008 Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol Med 14:11-19 (Pubitemid 351356881)